Innovatus to provide up to $42 mln to Personal Genome Diagnostics
Innovatus Capital Partners LLC has agreed to provide up to $42 million to Personal Genome Diagnostics Inc. Based in Baltimore, Personal Genome Diagnostics Inc is a developer of tissue-based and liquid biopsy technologies for cancer genomics.





